Prosecution Insights
Last updated: August 17, 2026

Examiner: DUBOSE, LAUREN

Tech Center 3700 • Art Units: 3771

This examiner grants 60% of resolved cases

Performance Statistics

60.1%
Allow Rate
-9.9% vs TC avg
195
Total Applications
+44.1%
Interview Lift
1123
Avg Prosecution Days
Based on 138 resolved cases, 2023–2026

Rejection Statute Breakdown

0.3%
§101 Eligibility
23.5%
§102 Novelty
52.0%
§103 Obviousness
22.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19018839 SYSTEM, DEVICE AND METHOD FOR TREATING TISSUE Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
19003636 SUTURE NEEDLE DEVICES AND SUTURE ATTACHMENT METHODS Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18830928 DEVICES, SYSTEMS, AND METHODS FOR SECURING TISSUE Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18483325 NECTROTIC TISSUE DEBRIDEMENT DEVICE Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18220999 Thrombectomy Apparatuses and Methods Non-Final OA Boston Scientific Scimed, Inc.
17966598 LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH ANTI-THROMBOGENIC COVERING Final Rejection BOSTON SCIENTIFIC SCIMED, INC.
18375913 INVERTING THROMBECTOMY APPARATUSES AND METHODS OF USE Final Rejection Stryker Corporation
17260597 SURGICAL INSTRUMENTS WITH REDUCED CAPACITANCE, RELATED DEVICES, AND RELATED METHODS Non-Final OA INTUITIVE SURGICAL OPERATIONS, INC.
17798592 ABDOMINAL HEMORRHAGE CONTROL DEVICE AND METHOD Non-Final OA THE REGENTS OF THE UNIVERSITY OF MICHIGAN
17632114 GASTROESOPHAGEAL AORTIC OCCLUSION DEVICE AND METHOD Final Rejection THE REGENTS OF THE UNIVERSITY OF MICHIGAN
17859651 TISSUE RESECTING INSTRUMENTS INCLUDING AUXILIARY VACUUM FEATURES Final Rejection Covidien LP
18719903 SUTURE NEEDLE GUIDE TUBE AND TISSUE SUTURING DEVICE TECHNICAL FIELD Non-Final OA Cilag GmbH International
18415133 SURGICAL INSTRUMENT WITH ELASTOMERIC DISTAL PIPE AND RELATED METHODS Final Rejection Cilag GmbH International
18294074 VASCULAR PLUG Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
18560784 SKIN TREATMENT SYSTEMS AND METHODS Non-Final OA Cytrellis Biosystems, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month